New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
07:55 EDTCVS, ESRX, CTRXLeerink a buyer of Catamaran ahead of Q2 results
Leerink says it's a buyer of Catamaran (CTRX) ahead of the company's Q2 results as it believes shares have more room to run. The firm is cautious on Express Scripts (ESRX) after hearing from a specialist that service challenges may impact the company's 2015 and 2016 selling seasons. The firm remains positive on CVS Caremark (CVS), but notes shares have outperformed and the company could see retail pressure from recent drug inflation trends.
News For CTRX;ESRX;CVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
February 9, 2016
08:42 EDTCVSCVS Health sees Q1 revenue growth of 17%-18.5%, consensus $42.96B
08:41 EDTCVSCVS Health sees FY16 PBM revenue growth of 20.25%-21.75%
Subscribe for More Information
08:39 EDTCVSCVS Health backs FY16 adjusted EPS $5.73-$5.88, consensus $5.83
Subscribe for More Information
08:38 EDTCVSCVS Health expects to return more than $5B to shareholders in 2016
Subscribe for More Information
08:35 EDTCVSCVS Health expects Medicare Part D to maintain market share position in 2016
08:34 EDTCVSCVS Health expects Target Pharmacy integration to be completed by end of summer
Subscribe for More Information
08:33 EDTCVSCVS Health expects to complete majority of Omnicare integration by year end
Subscribe for More Information
08:32 EDTCVSCVS Health added 500K net lives in 2016 for SilverScript
Subscribe for More Information
06:55 EDTCVSCVS Health backs Q1 adjusted EPS view of $1.14-$1.17
Subscribe for More Information
06:53 EDTCVSCVS Health reports Q4 pharmacy same store prescription volumes up 5%
06:53 EDTCVSCVS Health reports Q4 SSS up 3.5%
Subscribe for More Information
06:52 EDTCVSCVS Health reports Q4 adjusted EPS $1.53, consensus $1.53
Reports Q4 revenue $41.15B, consensus $4.18B.
February 8, 2016
14:28 EDTCVSNotable companies reporting before tomorrow's open
Subscribe for More Information
07:58 EDTCVSCVS Health volatility elevated into Q4 and outlook
Subscribe for More Information
February 5, 2016
10:08 EDTESRXExpress Scripts calls active
Subscribe for More Information
February 3, 2016
09:32 EDTCVSCVS Health initiated with an Overweight at Atlantic Equities
Target $114.
February 1, 2016
13:20 EDTCVSCVS Health to make overdose-reversing drug available without prescription in OH
Subscribe for More Information
10:51 EDTCVSActive calls; INTC CVS TWTR APC BAC
Subscribe for More Information
January 29, 2016
10:13 EDTESRXExpress Scripts to exclude Valeant's Glumetza from formulary
Subscribe for More Information
January 28, 2016
06:24 EDTESRXAnthem added to Focus List at Citi
Citi analyst Ralph Giacobbe added Anthem (ANTM) to his firm's Focus List. As Anthem and Express Scripts (ESRX) continue to negotiate their pharmacy benefits manager contract, the analyst sees UnitedHealth (UNH) as a potential alternative for Anthem. Regardless of the outcome, Anthem is in the "driver's seat for significant savings/upside," which is not reflected in the stock. Giacobbe tells investors in a research note. He keeps a Buy rating on the name with a $172 price target.
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use